CDK4/6 inhibitor-statin interaction and rhabdomyolysis in breast cancer treatment: a case-based systematic review.
Saved in:
| Title: | CDK4/6 inhibitor-statin interaction and rhabdomyolysis in breast cancer treatment: a case-based systematic review. |
|---|---|
| Authors: | João RB; Neurology and Neurophysiology Department, Goiânia Neurological Institute, Goiânia, Goiás, Brazil., Soares LR; CORA - Advanced Center for Diagnosis of Breast Diseases, School of Medicine and Hospital das Clínicas, Federal University of Goiás, Goiás, Brazil.; IMO Mastology and Oncology Institute, Goiânia, Goiás, Brazil.; Gynecology and Breast Department, Araújo Jorge Cancer Hospital, Goiás Anticancer Association, Goiânia, Goiás, Brazil., Ragazzo PC; Neurology and Neurophysiology Department, Goiânia Neurological Institute, Goiânia, Goiás, Brazil., Freitas-Junior R; CORA - Advanced Center for Diagnosis of Breast Diseases, School of Medicine and Hospital das Clínicas, Federal University of Goiás, Goiás, Brazil. ruffojr@terra.com.br.; IMO Mastology and Oncology Institute, Goiânia, Goiás, Brazil. ruffojr@terra.com.br.; Gynecology and Breast Department, Araújo Jorge Cancer Hospital, Goiás Anticancer Association, Goiânia, Goiás, Brazil. ruffojr@terra.com.br. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2026 Jul 01; Vol. 96 (1). Date of Electronic Publication: 2026 Jul 01. |
| Publication Type: | Journal Article; Systematic Review |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
